Three years after the accelerated approval of its anti-amyloid Alzheimer’s therapy, Biogen—neck and neck in the market with ...
As with the intravenous form, subcutaneous anifrolumab shows clinically meaningful benefits and favorable safety when added ...
Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...
Struggling with blind pimples? Learn how to treat cystic acne fast with dermatologist-approved products and proven at-home ...
Everyday Health on MSN
IVIg to SCIg: Considerations When Switching Immunoglobulin Therapies for Primary Immunodeficiency
Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, ...
Microgravity experiments on the International Space Station helped Merck develop a faster subcutaneous version of Keytruda (pembrolizumab). This new injection cuts treatment time to minutes, improving ...
Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with ...
US Oncologists anticipate rapid biosimilar uptake - up to 50% of PD-1/PD-L1 eligible patients within the first year - while ...
Shedding pounds almost invariably brings health benefits. But until now, it has been unclear to what extent weight loss also ...
The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...
AstraZeneca (NASDAQ: AZN) is one of the best future stocks to buy for the long term. On January 6, Barclays analyst James ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback